Role of perioperative immunotherapy in localized renal cell carcinoma

Medicine and Dentistry

• Clear Cell Renal Cell Carcinoma 100%
• Combination Therapy 33%
• Disease 33%
• Immunotherapy 100%
• Kidney Metastasis 66%
• Monotherapy 33%
• Partial Nephrectomy 33%
• Protein Tyrosine Kinase 33%
• Radical Nephrectomy 33%
• Recurrence Risk 33%
• Surgery 33%
• Survival Rate 33%
• Therapeutic Procedure 66%
• Tyrosine-Kinase Inhibitor 33%
• Vasculotropin Receptor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 33%
• Immunotherapy 100%
• Kidney Metastasis 66%
• Monotherapy 33%
• Protein Tyrosine Kinase 33%
• Protein Tyrosine Kinase Inhibitor 33%
• Recurrence Risk 33%
• Renal Cell Carcinoma 100%
• Survival Rate 33%
• Vasculotropin Receptor 33%